Hospital systems are turning to cross-market mergers to satiate their thirst for growth and avoid antitrust heat.March 6, 2023Check out STAT+Sponsored By Kin Cheung/AP STAT+ | At genome-editing summit, experts worry that rule changes on embryo research in China fall short "The new measures fail to directly address how privately funded research and other social ventures will be monitored," said a critic. By Megan Molteni STAT+ | In North Carolina, a small hospital deal poses big antitrust questions Hospitals like Novant are still doing lower-profile deals, which could inevitably lead to higher insurance premiums in those communities. By Bob Herman STAT+ | Heart repair, risky genes, and AI: the buzz from a giant cardiovascular conference An implantable heart clip from Abbott led to reductions in death, an endorsement of a device whose benefits have long been divisive. By Damian Garde and Matthew Herper Adobe STAT+ | BridgeBio's treatment for genetic cause of dwarfism accelerates growth in small study The latest results, while incremental in the drug's path to the market, dramatically exceeded Wall Street's expectations. By Damian Garde STAT+ | With a potent new medicine, Merck marks a return to cardiology The medicine, sotatercept, appeared to yield numerous benefits for patients with a rare condition called pulmonary arterial hypertension. By Matthew Herper More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments